13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q1 2025 · Filed May 12, 2025 · Accession 0001395064-25-000055
Total Value
$16.2M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HilleVax, Inc. | 43157M102 | 6,724,000 | $9.8M | 60.21% |
| 2 | Ovid Therapeutics, Inc. | OVID | 5,750,000 | $1.8M | 11.08% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | XLO | 1,475,121 | $1.1M | 6.59% |
| 4 | Equillium, Inc. | EQ | 1,824,977 | $711,741 | 4.40% |
| 5 | American Well Corporation | AMWL | 77,733 | $612,539 | 3.78% |
| 6 | Ovid Therapeutics, Inc. | OVID | 1,781,996 | $555,805 | 3.43% |
| 7 | Shattuck Labs, Inc. | STTK | 515,619 | $489,838 | 3.02% |
| 8 | Lyell Immunopharma, Inc. | LYEL | 823,317 | $442,945 | 2.74% |
| 9 | Turnstone Biologics | 90042W100 | 895,824 | $367,288 | 2.27% |
| 10 | Rani Therapeutics Holdings, Inc. | RANI | 203,190 | $256,019 | 1.58% |
| 11 | Third Harmonic Bio, Inc. | 88427A107 | 36,835 | $127,817 | 0.79% |
| 12 | Standard Biotools, Inc. | LAB | 16,515 | $17,836 | 0.11% |